SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Renin-Angiotensin-Aldosterone System
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Wu, C.-K.
Right arrow Articles by Tsai, C.-T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, C.-K.
Right arrow Articles by Tsai, C.-T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Angiotensin II does not influence expression of sarcoplasmic reticulum Ca2 + ATPase in atrial myocytes

Cho-Kai Wu

Department of Internal Medicine, National Taiwan University College of Medicine and Hospital Yun-Lin Branch, Yun-Lin, Taiwan

Chuen-Den Tseng

Division of Cardiology, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan, cdtseng{at}ntu.edu.tw

Yin-Tsen Huang

Department of Family Medicine, Mackay Memorial Hospital, Taipei, Taiwan, fang31{at}ms39.hinet.net

Chia-Shan Hsieh

Division of Cardiology, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan

Wei-Shan Tsai

Department of Internal Medicine, National Taiwan University College of Medicine and Hospital Yun-Lin Branch, Yun-Lin, Taiwan

Jiunn-Lee Lin

Division of Cardiology, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan

Fu-Tien Chiang

Division of Cardiology, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan, Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan

Chia-Ti Tsai

Division of Cardiology, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan

Introduction. The sarcoplasmic reticulum Ca2+ ATPase (SERCA) is essential for the regulation of the intracellular calcium level in cardiomyocytes. Previous studies have found that angiotensin II (Ang II) decreased SERCA2 gene expression in ventricular myocytes. Alteration of SERCA activity is important in the mechanism of atrial fibrillation. The present study was undertaken to examine Ang II effects on atrial myocytes.

Materials and methods. An ~1.75-kb promoter region of SERCA2 gene was cloned with the pGL3 luciferase vector. The direct effects of Ang II on SERCA2 gene expression in HL-1 atrial myocytes were examined by promoter activity assay, followed by Western blot analysis for protein levels and quantitative real-time reverse transcription polymerase chain reaction for mRNA amounts.

Results. Ang II did not increase the promoter activity of the 1,754-bp promoter-receptor construct of the SERCA2 gene. The levels of SERCA2 protein and mRNA were also unchanged at different time points after Ang II treatment.

Conclusions. Although Ang II had prominent effects on SERCA2 in ventricular myocytes, it did not alter SERCA2 gene expression and protein levels in atrial myocytes. We provide a model for further investigation of the regulation of SERCA2 gene expression in atrial myocytes.

Key Words: angiotensin II • HL-1 cardiomyocytes • promoter • sarcoplasmic reticulum Ca2+ ATPase • transcriptional regulation

References

  • Periasamy M., Huke S. SERCA pump level is a critical determinant of Ca(2+) homeostasis and cardiac contractility. J Mol Cell Cardiol 2001;33:1053-63.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ver Heyen M., Heymans S., Antoons G. et al. Replacement of the muscle-specific sarcoplasmic reticulum Ca(2+)-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction-relaxation of the heart. Circ Res 2001;89:838-46.[Abstract/Free Full Text]
  • Brilla CG, Pick R., Tan LB et al. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 1990;67:1355-64.[Abstract/Free Full Text]
  • Ohkusa T., Ueyama T., Yamada J. et al. Alterations in cardiac sarcoplasmic reticulum Ca2+ regulatory proteins in the atrial tissue of patients with chronic atrial fibrillation. J Am Coll Cardiol 1999;34:255-63.[Abstract/Free Full Text]
  • Lai LP, Su MJ, Lin JL et al. Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atrial electrical remodeling. J Am Coll Cardiol 1999;33:1231-7.[Abstract/Free Full Text]
  • Cao K., Xia X., Shan Q. et al. Changes of sarcoplasmic reticular Ca(2+)-ATPase and IP(3)-I receptor mRNA expression in patients with atrial fibrillation. Chin Med J (Engl) 2002;115:664-7.[Medline] [Order article via Infotrieve]
  • Ju H., Scammel-La Fleur T., Dixon IM Altered mRNA abundance of calcium transport genes in cardiac myocytes induced by angiotensin II. J Mol Cell Cardiol 1996;28:1119-28.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Flesch M., Schiffer F., Zolk O. et al. Angiotensin receptor antagonism and angiotensin converting enzyme inhibition improve diastolic dysfunction and Ca(2+)-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathy. J Hypertens 1997;15:1001-09.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Tsai CT, Wang DL, Chen WP et al. Angiotensin II increases expression of alpha1c subunit of L-type calcium channel through a reactive oxygen species and cAMP response element-binding protein-dependent pathway in HL-1 myocytes. Circ Res 2007;100:1476-85.[Abstract/Free Full Text]
  • Claycomb WC, Lanson NA, Jr, Stallworth BS et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A 1998;95:2979-84.[Abstract/Free Full Text]
  • Tsai CT, Lai LP, Hwang JJ et al. Renin-angiotensin system component expression in the HL-1 atrial cell line and in a pig model of atrial fibrillation. J Hypertens 2008;26:570-82.[Web of Science][Medline] [Order article via Infotrieve]
  • Xiao HD, Fuchs S., Campbell DJ et al. Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. Am J Pathol 2004;165:1019-32.[Abstract/Free Full Text]
  • Lijnen P., Petrov V., van Pelt J. et al. Inhibition of superoxide dismutase induces collagen production in cardiac fibroblasts. Am J Hypertens 2008;21:1129-36.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Zhou J., Xu X., Liu JJ et al. Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes. Clin Exp Pharmacol Physiol 2007;34:1191-8.[Web of Science][Medline] [Order article via Infotrieve]
  • Trivieri MG, Oudit GY, Sah R. et al. Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction. Proc Natl Acad Sci U S A 2006;103:6043-8.[Abstract/Free Full Text]
  • Lin CC, Lin JL, Lin CS et al. Activation of the calcineurin-nuclear factor of activated T-cell signal transduction pathway in atrial fibrillation. Chest 2004;126:1926-32.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Terentyev D., Viatchenko-Karpinski S., Gyorke I. et al. Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: mechanism for hereditary arrhythmia. Proc Natl Acad Sci U S A 2003;100:11759-64.[Abstract/Free Full Text]
  • He H., Giordano FJ, Hilal-Dandan R. et al. Overexpression of the rat sarcoplasmic reticulum Ca2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation. J Clin Invest 1997;100:380-9.[Web of Science][Medline] [Order article via Infotrieve]
  • Ausma J., Dispersyn GD, Duimel H. et al. Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation. J Mol Cell Cardiol 2000;32:355-64.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Sun H., Chartier D., Leblanc N. et al. Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes. Cardiovasc Res 2001;49:751-61.[Abstract/Free Full Text]
  • Shinagawa K., Mitamura H., Ogawa S. et al. Effects of inhibiting Na(+)/H(+)-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling. Cardiovasc Res 2002;54:438-46.[Abstract/Free Full Text]
  • Nakashima H., Kumagai K., Urata H. et al. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 2000;101:2612-17.[Abstract/Free Full Text]
  • Ducharme A., Swedberg K., Pfeffer MA et al. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Am Heart J 2006;152:86-92.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Schmieder RE, Kjeldsen SE, Julius S. et al. Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial. J Hypertens 2008;26:403-11.[Web of Science][Medline] [Order article via Infotrieve]
  • Vermes E., Tardif JC, Bourassa MG et al. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation 2003;107:2926-31.[Abstract/Free Full Text]
  • Healey JS, Baranchuk A., Crystal E. et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 2005;45:1832-9.[Abstract/Free Full Text]
  • Madrid AH, Bueno MG, Rebollo JM et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation 2002;106:331-6.[Abstract/Free Full Text]
  • Gassanov N., Brandt MC, Michels G. et al. Angiotensin II-induced changes of calcium sparks and ionic currents in human atrial myocytes: potential role for early remodeling in atrial fibrillation. Cell Calcium 2006;39:175-86.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Komuro I., Yazaki Y. Control of cardiac gene expression by mechanical stress. Annu Rev Physiol 1993;55:55-75.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Villegas S., Villarreal FJ, Dillmann WH Leukemia inhibitory factor and interleukin-6 downregulate sarcoplasmic reticulum Ca2+ ATPase (SERCA2) in cardiac myocytes. Basic Res Cardiol 2000;95:47-54.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Shah RD, Gonzales F., Golez E. et al. The antidiabetic agent rosiglitazone upregulates SERCA2 and enhances TNF-alpha- and LPS-induced NF-kappaB-dependent transcription and TNF-alphainduced IL-6 secretion in ventricular myocytes. Cell Physiol Biochem 2005;15:41-50.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Vangheluwe P., Schuermans M., Zador E. et al. Sarcolipin and phospholamban mRNA and protein expression in cardiac and skeletal muscle of different species. Biochem J 2005;359:151-9.

This version was published on September 1, 2009

Journal of Renin-Angiotensin-Aldosterone System, Vol. 10, No. 3, 121-126 (2009)
DOI: 10.1177/1470320309342732


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Wu, C.-K.
Right arrow Articles by Tsai, C.-T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, C.-K.
Right arrow Articles by Tsai, C.-T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Advertisement